📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
DCM Shriram Industries Shareholders Approve Key Management Appointments with Over 99% Majority
DCM Shriram Industries Limited has successfully passed four special resolutions through a postal ballot, all receiving over 99.8% shareholder approval. The resolutions confirm the appointments of Mr. Anurag Surana and Mr. Sidharth Prasad as Independent Directors, along with Mr. Uday Shriram as Deputy Managing Director and Mr. Rohan Shriram as Whole Time Director. Total voting participation stood at approximately 59.08% of the total shares, representing 51,397,080 votes. These appointments solidify the company's leadership team and governance framework for the upcoming term.
Key Highlights
Appointment of Mr. Uday Shriram as Deputy Managing Director approved with 99.89% votes in favour.
Mr. Rohan Shriram appointed as Whole Time Director with 99.89% shareholder support.
Independent Directors Anurag Surana and Sidharth Prasad secured 99.89% and 99.96% approval respectively.
Total voter turnout for the postal ballot was 51,397,080 shares, representing 59.08% of total capital.
💼 Action for Investors
The high approval ratings indicate strong shareholder confidence in the current management and proposed leadership. Investors should view this as a positive sign of leadership continuity and governance stability.
DCM Shriram Industries Clarifies Non-Submission of Consolidated Q3 FY26 Results
DCM Shriram Industries has clarified to the Exchange that it did not submit consolidated financial results for the quarter ended December 31, 2025, because it no longer has any subsidiaries or associates. This change is the result of a court-approved Scheme of Arrangement that became effective on December 17, 2025, demerging two business segments into independent entities. Consequently, former subsidiaries like DCM Shriram Fine Chemicals and DCM Shriram International have ceased to be part of the company's consolidated group. Investors should now view the company's financial performance on a standalone basis following this structural reorganization.
Key Highlights
Scheme of Arrangement became effective on December 17, 2025, after NCLT approval and ROC filing.
Two business segments were demerged into DCM Shriram Fine Chemicals Ltd and DCM Shriram International Ltd.
The company reported having zero subsidiaries, associates, or joint ventures as of the December 31, 2025 reporting date.
Consolidated financial statements are no longer applicable for the company following the restructuring.
The restructuring was effective retrospectively from April 1, 2023, for accounting purposes.
💼 Action for Investors
Investors should update their valuation models to reflect the company's new standalone structure and monitor the separate listing or performance of the demerged entities. No further consolidated reporting should be expected unless new subsidiaries are formed or acquired.
DCM Shriram Industries Q3 Net Profit Flat at ₹3.47 Cr Post-Demerger of Chemical & Rayon Units
DCM Shriram Industries reported a marginal increase in net profit to ₹3.47 crore for Q3 FY26, compared to ₹3.45 crore in the restated year-ago period. Revenue from operations saw a slight dip to ₹254.37 crore from ₹261.19 crore. The quarter was significant for the completion of a major corporate restructuring involving the demerger of the Chemical and Rayon businesses and the amalgamation of Lily Commercial Private Limited. Consequently, all historical figures have been restated to reflect only the continuing operations.
Key Highlights
Q3 FY26 Net Profit stood at ₹3.47 crore, nearly flat compared to ₹3.45 crore in Q3 FY25 (restated).
Revenue from operations for the quarter was ₹254.37 crore, a 2.6% decline from ₹261.19 crore YoY.
9M FY26 Net Profit reached ₹10.46 crore on a total income of ₹845.07 crore.
Demerger of Chemical and Rayon businesses finalized with an effective date of December 17, 2025, and retrospective accounting from April 1, 2023.
Amalgamation of Lily Commercial Private Limited completed, involving the cancellation and re-allotment of 50.11% of the company's equity shares to Lily's shareholders.
💼 Action for Investors
Investors should evaluate the company based on the restated financials as the demerger has significantly altered the business profile and asset base. Monitor the performance of the remaining core segments, primarily Sugar, to assess growth potential in the new leaner corporate structure.
DCM Shriram Industries Sets Cost Apportionment Ratio for Demerged Entities
DCM Shriram Industries has announced the cost of acquisition apportionment for its shareholders following the demerger of its Chemical and Rayon undertakings. For every 1 equity share held in the parent company, shareholders have been allotted 1 share each in DCM Shriram Fine Chemicals Limited and DCM Shriram International Limited. The cost of acquisition for the original shares will now be split among the three entities based on specific percentages for tax purposes. This update follows the scheme of arrangement that became effective on December 17, 2025.
Key Highlights
Cost of acquisition for DCM Shriram Industries Limited (Parent) is set at 42.66%
Cost of acquisition for DCM Shriram Fine Chemicals Limited is set at 25.22%
Cost of acquisition for DCM Shriram International Limited is set at 32.12%
Share entitlement ratio is 1:1:1 for the parent and the two resulting companies
The apportionment is based on the net book value of assets transferred as of the demerger date
💼 Action for Investors
Shareholders should use these ratios to adjust their purchase price records for tax compliance and capital gains calculations. No immediate action is required regarding the holding of the shares themselves.
DCM Shriram Industries Proposes Appointment of 4 Directors; E-voting Starts Jan 26
DCM Shriram Industries has issued a postal ballot notice to seek shareholder approval for four key board appointments. This includes two Independent Directors, Mr. Anurag Surana and Mr. Sidharth Prasad, for five-year terms ending in December 2030. Additionally, the company is seeking approval for Mr. Uday Shriram as Deputy Managing Director and Mr. Rohan Shriram as Whole Time Director, both for five-year terms starting December 23, 2025. The e-voting process is scheduled to run from January 26 to February 24, 2026.
Key Highlights
Appointment of two Independent Directors for 5-year terms ending December 9, 2030.
Mr. Uday Shriram and Mr. Rohan Shriram proposed for executive roles for 5-year terms from Dec 23, 2025.
Remote e-voting period scheduled from Jan 26, 2026, to Feb 24, 2026.
All four resolutions are proposed as Special Resolutions requiring 75% majority approval.
The cut-off date for determining shareholder voting eligibility was January 19, 2026.
💼 Action for Investors
Investors should review the professional backgrounds of the proposed directors to ensure leadership alignment with the company's growth strategy. No immediate portfolio action is required as these are standard governance procedures.
DCM Shriram Industries Completes Share Allotment for Demerger; Effective Date Dec 17, 2025
DCM Shriram Industries has finalized the allotment and credit of equity shares for its two resulting companies, DCM Shriram Fine Chemicals and DCM Shriram International, under a composite scheme of arrangement. The effective date of the scheme is confirmed as December 17, 2025, following the filing of NCLT orders. As a result, these entities have ceased to be subsidiaries and are now independent companies. Both resulting companies are currently seeking listing and trading permissions from the BSE and NSE to provide liquidity to shareholders.
Key Highlights
Effective date of the demerger scheme confirmed as December 17, 2025.
Shares of DCM Shriram Fine Chemicals and DCM Shriram International credited to eligible shareholders.
Resulting companies have ceased to be wholly-owned subsidiaries of DCM Shriram Industries.
Listing applications for the new entities are being processed with BSE and NSE.
Pre-scheme share capital of the resulting companies held by the parent has been cancelled.
💼 Action for Investors
Shareholders should verify the credit of new shares in their demat accounts and monitor upcoming exchange notifications for the listing dates of the two new entities.
DCM Shriram Industries Reconstitutes Board; Appoints New MD & CEO with Remuneration Hike
DCM Shriram Industries has announced a major board reconstitution following an NCLT-approved Scheme of Arrangement. Mr. Alok Bansidhar Shriram has resigned as Sr. MD & CEO, and Mr. Madhav Bansidhar Shriram has been redesignated as MD & CEO with a basic salary hike from Rs. 5.8 lakh to Rs. 7.5 lakh per month. Additionally, two new executive directors, Mr. Uday Shriram and Mr. Rohan Shriram, have been inducted to lead the restructured entity. The changes are part of a broader corporate reorganization involving the creation of two new resultant companies.
Key Highlights
Resignation of Mr. Alok Bansidhar Shriram (Sr. MD & CEO) and Mrs. Urvashi Tilakdhar (WTD) effective Dec 23, 2025.
Mr. Madhav Bansidhar Shriram redesignated as MD & CEO with basic salary increased to Rs. 7.5 lakh per month.
MD & CEO commission increased from up to 3% of PBT to up to 5% of PBT effective FY 2025-26.
Induction of Mr. Uday Shriram as Dy. Managing Director and Mr. Rohan Shriram as Whole Time Director.
Board changes implemented to facilitate the NCLT-approved Scheme of Arrangement involving three distinct corporate entities.
💼 Action for Investors
Investors should track the operational transition as the company implements its Scheme of Arrangement and monitor the performance of the new leadership team. The significant increase in MD remuneration and the induction of next-generation promoters suggest a long-term leadership transition.
DCM Shriram Industries Revises Record Date for Demerger to December 26, 2025
DCM Shriram Industries Limited has announced a revision in the record date for its corporate restructuring plan from December 19 to December 26, 2025. This restructuring involves the allotment of shares in two new entities: DCM Shriram Fine Chemicals Limited and DCM Shriram International Limited. The delay is attributed to administrative formalities regarding the extinguishment and allotment of shares involving Lily Commercial Pvt. Limited. Shareholders holding the stock as of the new record date will be eligible for the share allotment in the resultant companies.
Key Highlights
Revised Record Date for the Scheme of Arrangement is now December 26, 2025.
The previous record date was set for December 19, 2025.
Entitlement includes shares in two new entities: DCM Shriram Fine Chemicals and DCM Shriram International.
Delay caused by pending formalities related to the transferor company, Lily Commercial Pvt. Limited.
💼 Action for Investors
Investors interested in receiving shares of the two demerged entities must ensure they hold the stock until the revised record date of December 26, 2025. No immediate action is required other than noting the one-week delay in the process.
DCM Shriram Industries: Record Date for Scheme of Arrangement is 19-Dec-2025
DCM Shriram Industries Limited announced a record date of December 19, 2025, for the Composite Scheme of Arrangement. Shareholders will receive one fully paid-up share of ₹2 in each of the two resultant companies, DCM Shriram Fine Chemicals (DSFCL) and DCM Shriram International Limited (DSIL), for every share held in DCM Shriram Industries. The equity shares of each Resultant Companies will be issued to the shareholders of DCM Shriram Industries Limited (DCMSR) in the ratio of 1:1. This follows the NCLT's sanction of the scheme involving Lily Commercial Private Limited, DCM Shriram Fine Chemicals Limited, and DCM Shriram International Limited.
Key Highlights
Record date is 19-Dec-2025 for the Composite Scheme of Arrangement.
Shareholders receive one share in each of DSFCL and DSIL for every share in DCM Shriram Industries.
Equity Shares of each Resultant Companies will be issued to the shareholders of DCM Shriram Industries Limited (DCMSR) in the ratio of 1:1.
Scheme involves Lily Commercial Private Limited, DCM Shriram Fine Chemicals Limited, and DCM Shriram International Limited.
💼 Action for Investors
Shareholders should note the record date of December 19, 2025, to be eligible for the share allocation in DCM Shriram Fine Chemicals and DCM Shriram International. Monitor further announcements regarding the scheme's effectiveness after filing with the Registrar of Companies.
DCM Shriram Industries Appoints Anurag Surana and Sidharth Prasad as Independent Directors
DCM Shriram Industries has appointed Mr. Anurag Surana and Mr. Sidharth Prasad as Independent Directors effective December 10, 2025. Mr. Surana brings over 35 years of experience in the chemical industry, including a 20-year tenure at PI Industries where he served as Executive Director for 14 years. Mr. Prasad adds significant expertise in the sugar and energy sectors, currently serving on the board of L.H. Sugar Factories which operates a 12,500 TCD crushing capacity. These appointments are expected to strengthen the board's strategic oversight in the company's core business segments.
Key Highlights
Appointment of Mr. Anurag Surana and Mr. Sidharth Prasad as Independent Directors effective Dec 10, 2025
Mr. Surana has 35+ years of experience in agrochemicals and was an Executive Director at PI Industries for 14 years
Mr. Prasad manages sugar operations with 12,500 TCD crushing and 160 KLPD ethanol production capacity
Both directors confirmed they are not debarred from holding office by SEBI or any other authority
The appointments aim to enhance board expertise in chemicals, sugar, and strategic growth
💼 Action for Investors
Investors should view these appointments as a positive move to bring in seasoned industry veterans to the board. The addition of a former PI Industries leader is particularly noteworthy for the company's chemical business prospects.